The USP8 inhibitor 9-ethyloxyimino-9H-indeno[1,2-b] pyrazine-2,3-dicarbonitrile suppresses growth of non-small cell lung carcinoma (NSCLC) cells [38]. Here, USP8 is linked to non-small cell lung carcinoma.